EvaluatePharma USA, Inc. 
EvaluatePharma®, leader in life science sector analysis, delivers exclusive commercial intelligence and analysis into industry performance globally.
With 10+ years’ experience and investment in our services, we provide meaningful, value-added information and analysis that aids in target identification, strategic decision-making, and risk mitigation aimed towards your competitive advantage and business results.
Our flexible, “one-stop” services include:
EvaluatePharma® featuring all the Deals Data you need for Business Development, Proprietary Data Standardization, Merge Company tool, Calendar of Events, Interactive NPV Analyzer, Sales by Indication and Consensus Forecasts for Marketed & Pipeline Products, plus much more to give you the most accurate view of the global market.
EP Clinical Trials simplifies complex analysis of the global clinical trials landscape including ClinicalTrials.gov, EudraCT and Japan clinical trials data source for trusted clinical intelligence you can rely on, and the time savings you need.
EvaluatePharma® Partnering Services make finding your next licensing partner easier, and features the latest assets available for partnering presented in their commercial context alongside our unique industry analysis.
EPVantage® renowned news service provides mapped commentary and analysis that keeps you abreast of the latest sector developments relevant to you.
Discover why EvaluatePharma is trusted and relied upon by life science companies big and small, the investment community and leading consultancies.
You can count on EvaluatePharma for:
• Product Forecasts to 2018
• New – Sales by Indication to 2018
• Product Deals
• M&A Transactions
• Product Historic Sales
• Clinical Trials
• Country Analysis
• Archived Historical Sales Forecasts
• Company profiles
• Drug Information
• R&D Pipelines
• Patent Risk
• News
• NPV’s of Marketed and Pipeline Products
• Calendar of Events - key events that will shape the future of the industry
• EP Vantage & Event Analyzer - analysis and commentary on key market events
| Partnering strategy/collaborations |
| We encourage all biotechnology companies and research organizations with developmental products available to out-license to post their licensing details to our Partnering Opportunities service. This new free service allows potential partners to see your Partnering Opportunities in their commercial context, alongside EvaluatePharma®’s unique industry analysis, including product portfolios, company financials and reference deal terms. |
| Client portfolio |
|
EvaluatePharma® has a global audience of business development and licensing professionals at the world's leading pharmaceuticals and biopharmaceuticals companies - we have Users at 85 of the top 100 pharma companies, worldwide, with more signing up every day. We look forward to meeting you at the conference! |
Miss Heather Dragon
Manager, Sales & Solutions
Ms Courtney Cote
West Coast Manager, Sales & Solutions
